Anti-polyribosylribitol phosphate antibody concentrations and avidities in children since the start of Haemophilus influenzae type b immunization of infants in the United Kingdom.

Anti-polyribosylribitol phosphate antibody concentrations and avidities in children since the start of Haemophilus influenzae type b immunization of infants in the United Kingdom.

The introduction of routine infant immunization with Haemophilus influenzae type b (Hib) conjugate vaccines in the United Kingdom in 1992 led to a significant reduction in invasive disease due to this organism. Subsequently, between 1999 and 2003 there was an increase in the number of immunized chil...

Bibliografski detalji
Glavni autori:	Kelly, D, Moxon, E, Yu, L, Pollard, A
Format:	Journal article
Jezik:	English
Izdano:	2009

Slični predmeti

PECULIARITIES OF CULTIVATION OF HAEMOPHILUS INFLUENZAE TYPE B STRAINS - PRODUCERS OF POLYRIBOSYLRIBITOL PHOSPHATE - THE MAIN COMPONENT OF POLYSACCHARIDE VACCINES
od: E. L. Salimova, i dr.
Izdano: (2017-10-01)

THE SAFETY OF HAEMOPHILUS INFLUENZAE TYPE B/POLYRIBOSYLRIBITOL PHOSPHATE-TETANUS (HIB/PRP-T) VACCINE, PHASE I STUDY
od: Kusnandi Rusmil, i dr.
Izdano: (2015-09-01)

Enzyme-linked Immunosorbent Assay (ELISA) for Measurement of Antibody against Polyribosylribitol Phosphate Polysaccharide Capsule Extracted from Haemophilus Influenza Type-B Strain-Atf2
od: Shafagh Khademi, i dr.
Izdano: (2016-05-01)

Haemophilus influenzae type b conjugate vaccines
od: Kelly, D, i dr.
Izdano: (2004)

Haemophilus influenzae type b conjugate vaccines.
od: Kelly, D, i dr.
Izdano: (2004)

TECHNOLOGY OF OBTAINING POLYRIBOSYLRIBITOL PHOSPHATE AS AN ACTIVE PHARMACEUTICAL INGREDIENT FOR THE PRODUCTION OF POLYSACCHARIDE VACCINES
od: E. L. Salimova, i dr.
Izdano: (2018-03-01)

Antibody persistence and Haemophilus influenzae type b carriage after infant immunisation with PRP-T.
od: Heath, P, i dr.
Izdano: (1997)

Immunogenicity of routine vaccination against diphtheria, tetanus, and Haemophilus influenzae type b in Asian infants born in the United Kingdom.
od: Booy, R, i dr.
Izdano: (2005)

Is Haemophilus influenzae type b disease finished?
od: Kelly, D, i dr.
Izdano: (2004)

Haemophilus influenzae lipopolysaccharide.
od: Hood, D, i dr.
Izdano: (1999)

School-aged children: a reservoir for continued circulation of Haemophilus influenzae type b in the United Kingdom.
od: Oh, S, i dr.
Izdano: (2008)

School-aged children: a reservoir for continued circulation of Haemophilus influenzae Type b in the United Kingdom
od: Oh, S, i dr.
Izdano: (2008)

Molecular Methods for Haemophilus influenzae.
od: Herbert, M, i dr.
Izdano: (1998)

Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
od: Lee, Y, i dr.
Izdano: (2008)

Haemophilus influenzae Type b vaccine failure in children is associated with inadequate production of high-quality antibody
od: Lee, Y, i dr.
Izdano: (2008)

Production of low-avidity antibody by infants after infection with serogroup B meningococci.
od: Pollard, A, i dr.
Izdano: (2000)

Immunologic memory in Haemophilus influenzae type b conjugate vaccine failure.
od: McVernon, J, i dr.
Izdano: (2003)

Occurrence of Haemophilus influenzae strains in three Brazilian states since the introduction of a conjugate Haemophilus influenzae type b vaccine
od: A.E.C.C. de Almeida, i dr.
Izdano: (2005-05-01)

Haemophilus influenzae biofilms: hypothesis or fact?
od: Moxon, E, i dr.
Izdano: (2008)

The role of antibody concentration and avidity in antiviral protection.
od: Bachmann, M, i dr.
Izdano: (1997)

PCR for capsular typing of Haemophilus influenzae.
od: Falla, T, i dr.
Izdano: (1994)

Simple sequence repeats in Haemophilus influenzae.
od: Power, P, i dr.
Izdano: (2009)

Evaluation of haemophilus influenzae type b vaccine for routine immunization in Nepali infants.
od: Metz, J, i dr.
Izdano: (2012)

Cardiac transplantation and immunisation against Haemophilus influenzae.
od: Barbour, M, i dr.
Izdano: (1993)

Model-based inference of neutralizing antibody avidities against influenza virus.
od: Janina Linnik, i dr.
Izdano: (2022-01-01)

Long-term immunological follow-up of children with haemophilus influenzae serotype b vaccine failure in the United Kingdom.
od: Ladhani, S, i dr.
Izdano: (2009)

Phosphorylcholine allows for evasion of bactericidal antibody by Haemophilus influenzae.
od: Sarah E Clark, i dr.
Izdano: (2012-01-01)

Haemophilus influenzae and the lung (Haemophilus and the lung)
od: Paul King
Izdano: (2012-12-01)

The impact of conjugate vaccine on carriage of Haemophilus influenzae type b.
od: Barbour, M, i dr.
Izdano: (1995)

Bacterial lipopolysaccharides: candidate vaccines to prevent Neisseria meningitidis and Haemophilus influenzae infections.
od: Moxon, E, i dr.
Izdano: (1998)

Primary haemophilus influenzae pyomyositis in an infant: a case report
od: Gülten Seçmeer, i dr.
Izdano: (2003-04-01)

Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide-CRM197 (HbOC) conjugate vaccine.
od: Barbour, M, i dr.
Izdano: (1993)

DNA repeats identify novel virulence genes in Haemophilus influenzae.
od: Hood, D, i dr.
Izdano: (1996)

AVIDITY EVALUATION OF LOCAL IgA ANTIBODIES IN PERSONS IMMUNIZED WITH LIVE INFLUENZA VACCINE
od: S. A. Donina, i dr.
Izdano: (2014-07-01)

The Comparison of Haemophilus Influenza in the Throat of Healthy Infants with Different Feeding Methods
od: A Kazemi, i dr.
Izdano: (2004-06-01)

Structural analysis of the lipopolysaccharide from nontypeable Haemophilus influenzae strain R2846.
od: Lundström, S, i dr.
Izdano: (2008)

Characterization of capsular genes in Haemophilus influenzae isolates from H. influenzae type b vaccine recipients.
od: Falla, T, i dr.
Izdano: (1995)

A tool for evaluating heterogeneity in avidity of polyclonal antibodies
od: Li, K, i dr.
Izdano: (2023)

A tool for evaluating heterogeneity in avidity of polyclonal antibodies
od: Kan Li, i dr.
Izdano: (2023-02-01)

Characterization of novel structural features in the lipopolysaccharide of nondisease associated nontypeable Haemophilus influenzae.
od: Landerholm, M, i dr.
Izdano: (2004)